.
Summary Favorable Q4 figures bring out optimism amongst investors New acquisitions and a new joint venture with Pfizer could lead to something huge Higher-than-average yield also comes with its share of uncertainty GlaxoSmithKline (GSK) has built over the years a pharmaceutical empire. R&D numbers reaching billions, new discoveries leading to newly marketed products as well […]
Summary Q4 figures give an overview of the company’s satisfying position Acquisitions seem to be a winning formula for healthy margins While not alarming, uncertainties start to rise on multiple levels With everything a consumer buys, it’s easy to forget about the “little things”. But those so-called little things, are often essential components to many […]
Summary One of the best quarter in the company’s history, with a 39% EPS increase. Betting on technology might be the key to success for the transportation business. A rocky road lays ahead with intensive competition showing up. Expeditors International of Washington (EXPD) has observed a healthy growth during the last few years. The growth […]
Today I’m going to war. I’m taking my double-sided axe and putting my mean face on. I will need the warrior spirit because I’m about to tackle one of investing’s sacred beasts: high dividend yielding stocks. Dividend investing is quite popular among income-seeking investors. If you intend to live off your portfolio revenues, what could […]
With the market going sideways for the past few months, both US and Canadian markets are on their way to close 2018 in negative territories. There are lots of fluctuations as many investors realize they don’t have the stomach to ride such markets. Each year, I make the publication of a book titled “Best Dividend […]
Receive dividend stock ideas and exclusive investing strategies with this dividend stock newsletter.
No cost, just content.
